469 related articles for article (PubMed ID: 11574733)
1. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
4. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Chenoweth DE; Cheung AK; Henderson LW
Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
[TBL] [Abstract][Full Text] [Related]
5. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
[TBL] [Abstract][Full Text] [Related]
6. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
[TBL] [Abstract][Full Text] [Related]
8. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes.
Frith SE; Hoenich NA; Redfern CP; Goodship TH
Int J Artif Organs; 1994 Sep; 17(9):478-87. PubMed ID: 7890436
[TBL] [Abstract][Full Text] [Related]
9. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of different hemodialysis and plasmapheresis membranes.
Jørstad S
Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
[TBL] [Abstract][Full Text] [Related]
11. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
[TBL] [Abstract][Full Text] [Related]
12. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
[TBL] [Abstract][Full Text] [Related]
13. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
[TBL] [Abstract][Full Text] [Related]
14. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
16. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of artificial organs: an overview.
Henderson LW; Chenoweth D
Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
[TBL] [Abstract][Full Text] [Related]
18. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
[TBL] [Abstract][Full Text] [Related]
19. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible?
Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH
Am J Kidney Dis; 1995 Jun; 25(6):896-903. PubMed ID: 7771486
[TBL] [Abstract][Full Text] [Related]
20. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
